1. Others NF-κB Immunology/Inflammation Metabolic Enzyme/Protease Apoptosis
  2. Reactive Oxygen Species (ROS) Environmental Pollutants Endogenous Metabolite Apoptosis
  3. β-Carotene

β-Carotene  (Synonyms: Provitamin A; beta-Carotene)

Cat. No.: HY-N0411 Purity: 99.25%
Handling Instructions Technical Support

β-Carotene (Provitamin A), a carotenoid compound, is a naturally-occurring vitamin A precursor. β-Carotene is a modulator of reactive oxygen species (ROS), with antioxidant and antiinflammatory activities. β-Carotene may serve as an antioxidant or as a prooxidant, depending on its intrinsic properties as well as on the redox potential of the biological environment in which it acts. β-Carotene induces breast cancer cells apoptosis, with anticancer activities.

For research use only. We do not sell to patients.

CAS No. : 7235-40-7

Size Price Stock Quantity
50 mg In-stock
100 mg In-stock
1 g In-stock
5 g In-stock
10 g In-stock
25 g In-stock
50 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 2 publication(s) in Google Scholar

Other Forms of β-Carotene:

Top Publications Citing Use of Products
Cell Proliferation/Viability Assay
Flow Cytometry
WB
IF

    β-Carotene purchased from MedChemExpress. Usage Cited in: Evid Based Complement Alternat Med. 2022 Jun 17:2022:2502263.

    The CCK-8 assay was used to measure the viability of IEC-6 cells. IEC-6 cells were treated with β-Carotene at the indicated doses (0, 1.25, 2.5, 5, 10, 20, 40, 80, and 100 μM) for 24 h.

    β-Carotene purchased from MedChemExpress. Usage Cited in: Evid Based Complement Alternat Med. 2022 Jun 17:2022:2502263.

    Cells were first treated with LPS (100 μM) for 3 hours, and then with β-Carotene (10, 20, and 30 μM) for 24 hours. Apoptosis was quantitatively analyzed by flow cytometry.

    β-Carotene purchased from MedChemExpress. Usage Cited in: Evid Based Complement Alternat Med. 2022 Jun 17:2022:2502263.

    Cells were first treated with LPS (100 μM) for 3 hours, and then with β-Carotene (10, 20, and 30 μM) for 24 hours. The expression of Bax, Bcl-2, and cleaved caspase-3 was detected by Western blot.

    β-Carotene purchased from MedChemExpress. Usage Cited in: Evid Based Complement Alternat Med. 2022 Jun 17:2022:2502263.

    Cells were exposed to LPS (100 μM) for 3 hours, then treated with β-Carotene (10 μM) and incubated for 24 hours with or without rapamycin (RAPA, 10 μM). Immunofluorescence was used to detect the formation of GFP-LC3 spots.

    β-Carotene purchased from MedChemExpress. Usage Cited in: Evid Based Complement Alternat Med. 2022 Jun 17:2022:2502263.

    Cells were pretreated with LPS (100 μM) for 3 hours, then with β-Carotene (10 μM), and cultured for another 24 hours with or without voxtalisib (5 μM). Cell viability was assessed using the CCK-8 assay.

    View All Endogenous Metabolite Isoform Specific Products:

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    β-Carotene (Provitamin A), a carotenoid compound, is a naturally-occurring vitamin A precursor. β-Carotene is a modulator of reactive oxygen species (ROS), with antioxidant and antiinflammatory activities. β-Carotene may serve as an antioxidant or as a prooxidant, depending on its intrinsic properties as well as on the redox potential of the biological environment in which it acts. β-Carotene induces breast cancer cells apoptosis, with anticancer activities[1][2][3][4][5].

    IC50 & Target[3]

    Human Endogenous Metabolite

     

    apoptosis

     

    Cellular Effect
    Cell Line Type Value Description References
    Raji IC50
    12.7 nM
    Compound: beta-carotene
    Inhibition of TPA-induced Epstein-Barr virus early antigen activation in Raji cells after 48 hrs
    Inhibition of TPA-induced Epstein-Barr virus early antigen activation in Raji cells after 48 hrs
    [PMID: 17503850]
    Raji IC50
    397 molar ratio
    Compound: Beta-carotene
    Inhibition of TPA-induced EBV early antigen activation in human Raji cells relative to TPA
    Inhibition of TPA-induced EBV early antigen activation in human Raji cells relative to TPA
    [PMID: 19746919]
    Raji IC50
    397 molar ratio
    Compound: beta-carotene
    Inhibition of TPA-induced EBV-early antigen activation in human Raji cells relative to TPA
    Inhibition of TPA-induced EBV-early antigen activation in human Raji cells relative to TPA
    [PMID: 17190444]
    Raji IC50
    400 molar ratio
    Compound: Beta-Carotene
    Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed per 32 pmol TPA
    Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed per 32 pmol TPA
    [PMID: 14695799]
    Raji IC50
    400 molar ratio
    Compound: Beta-carotene
    Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed per 32 pmol TPA by immunofluorescence technique
    Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed per 32 pmol TPA by immunofluorescence technique
    [PMID: 14695801]
    Raji IC50
    400 molar ratio
    Compound: beta-carotene
    Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as EA activation per 32 pmol TPA after 48 hrs
    Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as EA activation per 32 pmol TPA after 48 hrs
    [PMID: 11429990]
    Raji IC50
    400 molar ratio
    Compound: beta-carotene
    Inhibition of TPA-induced EBV-early antigen activation in human Raji cells per 32 pmol TPA after 48 hrs
    Inhibition of TPA-induced EBV-early antigen activation in human Raji cells per 32 pmol TPA after 48 hrs
    [PMID: 12608849]
    Raji IC50
    400 molar ratio
    Compound: beta-carotene
    Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as early antigen activation after 48 hrs relative to control
    Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as early antigen activation after 48 hrs relative to control
    [PMID: 12662094]
    In Vitro

    β-Carotene up-regulates PPAR-γ expression and ROS production in MCF-7 cancer cells[3].
    β-Carotene (1-100 μM; 72 hours) remarkably decreases the survival of MCF-7 cells in a dose-dependent manner[3].
    β-Carotene (50 μM; 24-72 hours) significantly enhances the expression levels of PPAR-γ mRNA and protein in a time-dependent manner[3].
    β-Carotene down-regulates the COX-2 but up-regulates the p21 mRNA level and protein expression in a time dependent manner[3].
    β-Carotene significantly increases the percentage of early apoptosis and the effect was partly attenuated by pre-incubation with GW9662 (HY-16578) or GSH (HY-D0187)[3].
    β-Carotene induces cytochrome C release[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Viability Assay[5]

    Cell Line: MCF-7 cells
    Concentration: 1 μM, 10 μM, 20 μM, 50 μM, 100 μM
    Incubation Time: 72 hours
    Result: Decreased the numbers of viable cells to 70% and 50% at 20 μM and 50 μM, respectively.

    RT-PCR[5]

    Cell Line: MCF-7 cells
    Concentration: 50 μM
    Incubation Time: 24 hours, 48 hours, 72 hours
    Result: Up-regulated the PPAR-γ mRNA.

    Western Blot Analysis[5]

    Cell Line: MCF-7 cells
    Concentration: 50 μM
    Incubation Time: 24 hours, 48 hours, 72 hours
    Result: Up-regulated PPAR-γ protein expression levels.

    Apoptosis Analysis[5]

    Cell Line: MCF-7 cells
    Concentration: 50 μM
    Incubation Time: 72 hours
    Result: Induced MCF-7 cells apoptosis.
    Clinical Trial
    Molecular Weight

    536.87

    Formula

    C40H56

    CAS No.
    Appearance

    Solid

    Color

    Brown to red

    SMILES

    CC1(C)C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C)=C(C)CCC1

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage

    -20°C, protect from light, stored under nitrogen

    *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)

    Solvent & Solubility
    In Vitro: 

    THF : 10 mg/mL (18.63 mM; ultrasonic and warming and heat to 60°C)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 1.8626 mL 9.3132 mL 18.6265 mL
    5 mM 0.3725 mL 1.8626 mL 3.7253 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    Purity & Documentation

    Purity: 99.25%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    THF 1 mM 1.8626 mL 9.3132 mL 18.6265 mL 46.5662 mL
    5 mM 0.3725 mL 1.8626 mL 3.7253 mL 9.3132 mL
    10 mM 0.1863 mL 0.9313 mL 1.8626 mL 4.6566 mL
    15 mM 0.1242 mL 0.6209 mL 1.2418 mL 3.1044 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    β-Carotene
    Cat. No.:
    HY-N0411
    Quantity:
    MCE Japan Authorized Agent: